Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.

Berkowitz SD. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease. Haemostasis. 2000; 30 Suppl 3:27-43.

View in: PubMed

subject areas

Acetates
Angina, Unstable
Angioplasty, Balloon, Coronary
Animals
Antibodies, Monoclonal
Coronary Artery Bypass
Coronary Disease
Drug Approval
Hemorrhage
Humans
Immunoglobulin Fab Fragments
Mice
Multicenter Studies as Topic
Myocardial Ischemia
Peptides
Platelet Aggregation
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Randomized Controlled Trials as Topic
Recombinant Fusion Proteins
Recurrence
Safety
Single-Blind Method
Stents
Survival Analysis
Treatment Outcome
Tyrosine
United States
United States Food and Drug Administration

authors with profiles

Scott Darrell Berkowitz

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium